Inspira Technologies Announces Annual and Extraordinary General Meeting for December 2025

Inspira Technologies Oxy BHN ( (IINN) ) just unveiled an announcement.

Inspira Technologies Oxy B.H.N. Ltd. has announced its upcoming Annual and Extraordinary General Meeting of Shareholders, scheduled for December 30, 2025, in Ra’anana, Israel. The meeting will address several key proposals, including the re-appointment of Ziv Haft as the company’s independent auditor, the re-election of board members, and the approval of restricted share units for a new director. This meeting is significant for stakeholders as it involves decisions on leadership and financial oversight, impacting the company’s strategic direction and governance.

The most recent analyst rating on (IINN) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.

Spark’s Take on IINN Stock

According to Spark, TipRanks’ AI Analyst, IINN is a Underperform.

The overall stock score reflects significant financial instability, as indicated by ongoing losses and reliance on external funding. The technical analysis shows bearish sentiment, with the stock under pressure. Valuation is challenging due to negative earnings and lack of dividend yield, making the stock less appealing to investors.

To see Spark’s full report on IINN stock, click here.

More about Inspira Technologies Oxy BHN

Inspira Technologies Oxy B.H.N. Ltd. operates in the medical technology industry, focusing on the development of respiratory support technologies. The company is known for its innovative products aimed at improving patient care in critical care settings.

Average Trading Volume: 286,116

Technical Sentiment Signal: Sell

Current Market Cap: $24.68M

Find detailed analytics on IINN stock on TipRanks’ Stock Analysis page.